The 1st Annual Cancer Bioinformatics Symposium at the University of Toledo College of Medicine and Life Sciences will take place February 5th. The full day, online event champions collaboration between...Read More
Journal for ImmunoTherapy of Cancer published the results of a study focusing on the potential of kinase activity profiling to predict the response of Melanoma and Non Small Cell Lung...Read More
“I’m focused on continuous improvement of therapeutic strategies and to translate these into solutions for patients suffering from lung diseases,” tells Dr. Astrid Weiß, post doc. at the Biomedical Research...Read More
“When you combine traditional laboratory techniques with advanced computational biology techniques, you can significantly improve the quality and quantity of your research and produce experimental results that give you much...Read More
Blood-based biomarker test has the potential to decrease the number of both over- and undertreated patients improving overall response rate, reduce unnecessary side effects and help saving costs. PamGene, a...Read More
PamGene, a biotech and services company focused on the development and commercialization of multiple novel biomarker panels for patient stratification in immuno-oncology, is pleased to announce that new data from...Read More
The University of Toledo College of Medicine and Life SciencesDepartment of Neurosciences invites you to: A Virtual Mini Symposium: Computation Modeling Signaling Change: Interrogating Protein Kinase signaling with Bioinformatics and Computational...Read More
Checking in on Biochemical Kinase behaviour Real-time measurement and understanding of kinase activity serve many purposes. It allows insights in cellular signaling and pathway elucidation but also target interactions. Recently...Read More
On February 18, 2019 PamGene has received the Certificate of Approval by Lloyd’s Register for the ISO 13485:2016 for it’s Management System. PamGene has developed a blood-based diagnostic test with...Read More
PamGene is active in the area of diagnostics research and is in the process of developing clinical biomarkers for therapy response. There is an urgent need to properly predict clinical...Read More
